Adjuvant Chemoradiotherapy for Gastric Carcinoma: Dosimetric Implications of Conventional Gastric Bed Irradiation and Toxicity

Clinical Oncology

Volumn 18, Issue 9, 2006, Pages 663-668

  Pemberton, L ^a   Coote, J ^b   Perry, L ^b   Khoo, V S ^c   Saunders, M P ^b  

^a WESTON PARK HOSPITAL   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Adjuvant; chemoradiotherapy; dosimetry; gastric cancer; toxicity

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BODY WEIGHT DISORDER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIARRHEA; DOSIMETRY; DRUG DOSE REGIMEN; DYSPEPSIA; DYSPHAGIA; FEASIBILITY STUDY; FEMALE; GASTRECTOMY; HISTOGRAM; HUMAN; KIDNEY; LIVER DYSFUNCTION; MALE; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION FIELD; RETROSPECTIVE STUDY; SIMULATION; SPINAL CORD; STOMACH CARCINOMA; TREATMENT WITHDRAWAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; RADIOMETRY; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 33749060633     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2006.06.012     Document Type: Article

References (21)

1. Wanebo H., Kennedy B.J., Chmiel J., et al. Cancer of the stomach: a patient care study by the American College of Surgeons. Ann Surg 218 (1993) 583-592
2. MacDonald J.S., Smalley S.R., Benedetti J., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastrointestinal junction. N Engl J Med 345 (2001) 725-730
3. Mari E., Floriani I., Tinazzi A., et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. Ann Oncol 11 7 (2000) 837-843
4. Earle C.C., and Maroun J.A. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur J Cancer 35 7 (1999) 1059-1064
5. Cirera L., Balil A., Batiste-Alentorn E., et al. Randomised clinical trial of adjuvant mitomycin plus tegafur in patients with resected stage 3 gastric cancer. J Clin Oncol 17 12 (1999) 3810-3815
6. Neri B., Cini G., Andreoli F., et al. Randomised trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up. Br J Cancer 84 7 (2001) 878-880
7. Cunningham D., Allum W., and Weeden S. Perioperative chemotherapy in operable gastric and lower oesophageal cancer: a randomised, controlled trial of the NCRI Upper GI Clinical Studies Group (the MAGIC trial, ISRCTN 93793971). Eur J Cancer 39 suppl 5 (2003) S18
8. Cunningham D, Allum WH, Stenning S, et al. ASCO 2005;23 [Abstract 4001] and oral presentation.
9. Kim S., Lim D.H., Lee J., et al. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with a D2 nodal dissection for adenocarcinoma of the stomach. Int J Radiat Oncol Biol Phys 63 (2005) 1279-1285
10. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
11. Trotti A., Byhardt R., Stetz J., et al. Common toxicity criteria: version 2. An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys 47 1 (2000) 13-47
12. Cuschieri A., Weeden S., Fielding J., et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomised surgical trial. Surgical Co-operative Group. Br J Cancer 79 (1999) 1522-1530
13. Bonencamp J.J., Hermans J., Sasako M., et al. Extended lymph node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med 340 (1999) 908-914
14. Hermans J., Bonenkamp J.J., Boon M.C., et al. Adjuvant therapy after curative resection of gastric cancer: meta-analysis of randomised trials. J Clin Oncol 11 8 (1993) 1441-1447
15. Park S.H., Kim D.Y., and Heo J.S. Postoperative chemoradiotherapy for gastric cancer. Ann Oncol 14 9 (2003) 1373-1377
16. Dawson L.A., Ten Haken R.K., and Lawrence T.S. Partial irradiation of the liver. Semin Radiat Oncol 11 3 (2001) 240-246
17. Lawrence T.S., Robertson J.M., Anscher M.S., et al. Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31 (1995) 1237-1248
18. Cassady R.J. Clinical radiation nephropathy. Int J Radiat Oncol Biol Phys 31 5 (1995) 1249-1256
19. Coia L.R., Myerson R.J., and Tepper J.E. Late effects of radiation therapy on the gastrointestinal tract. Int J Radiat Oncol Biol Phys 31 5 (1995) 1213-1236
20. Letschert J.G., Lebesque J.V., de Boer R.W., et al. Dose-volume correlation in radiation-related late small-bowel complications: a clinical study. Radiother Oncol 18 (1990) 307-320
21. Krook J.E. Effective surgical adjuvant therapy for high risk rectal carcinoma. N Engl J Med 324 (1991) 709-715